This is a news story, published by Yahoo, that relates primarily to Propecia news.
For more Propecia news, you can click here:
more Propecia newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
European drugs regulator. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest European Medicines Agency news, loss drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
brand name PropeciaReuters
•79% Informative
European drugs regulator reviewing anti hair-loss drugs for potential risk of suicidal thoughts and behaviour associated with them.
Oral anti-baldness drugs, which contain finasteride and dutasteride, have a known risk of psychiatric side effects, including depression.
These drugs are sold under the brand name Propecia and Avodart by Organon , a Merck spin-off, and British drugmaker GSK .
VR Score
88
Informative language
93
Neutral language
73
Article tone
formal
Language
English
Language complexity
58
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links